MedTrace Logo

Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

NCT04737408 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-02-05

No results posted yet for this study

Summary

The FLOW-PROMOTE Study is an investigator-initiated, Danish multicenter study of patients with stable chest pain investigating whether lipid lowering is associated with recovery of impaired coronary flow as assessed by CT derived fractional flow reserve (FFRCT).

Conditions

Interventions

DRUG

Rosuvastatin 40mg

Rosuvastatin 40 mg

Sponsors & Collaborators

  • Bjarne Linde Noergaard

    lead OTHER

Principal Investigators

  • Bjarne L Noergaard, MD, PhD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-13
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04737408 on ClinicalTrials.gov